Page 69 - Read Online
P. 69

Page 14 of 16                         Enrique et al. J Cancer Metastasis Treat 2019;5:54  I  http://dx.doi.org/10.20517/2394-4722.2019.20

               Conflicts of interest
               All authors declared that there are no conflicts of interest.


               Ethical approval and consent to participate
               Not applicable.


               Consent for publication
               Not applicable.


               Copyright
               © The Author(s) 2019.



               REFERENCES
               1.    Tabouret E, Bauchet L, Carpentier A. Épidémiologie des métastases cérébrales et tropisme cérébral. Bull Cancer 2013;100:57-62.
               2.   Schouten LJ, Rutten J, Huveneers HA, Twijnstra A. Incidence of brain metastases in a cohort of patients with carcinoma of the breast,
                   colon, kidney, and lung and melanoma. Cancer 2002;94:2698-705.
               3.   Fidler IJ. The biology of brain metastasis: challenges for therapy. Cancer 2015;21:284-93.
               4.   Conrad CA. Chemotherapy for metastatic tumors to the central nervous system. Curr Oncol Rep 2001;3:490-4.
               5.   Guõmundsson KR. A survey of tumours of the central nervous system in Iceland during the 10-year period 1954-1963. Acta Neurologica
                   Scandinavica 1970;46:538-52.
               6.   Percy AK, Elveback LR, Okazaki H, Kurland LT. Neoplasms of the central nervous system. Epidemiologic considerations. Neurol
                   1972;22:40e8.
               7.   Barnholtz-Sloan JS, Sloan AE, Davis FG, Vigneau FD, Lai P, et al. Incidence proportions of brain metastases in patients diagnosed
                   (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol 2004;22:2865-72.
               8.   Fox BD, Cheung VJ, Patel AJ, Suki D, Rao G. Epidemiology of metastatic brain tumors. Neurosurg Clin N Am 2011;22:1-6.
               9.   Schouten LJ, Rutten J, Huveneers HA, Twijnstra A. Incidence of brain metastases in a cohort of patients with carcinoma of the breast,
                   colon, kidney, and lung and melanoma. Cancer 2002;94:2698-705.
               10.   Suki D. The epidemiology of brain metastasis. In: Sawaya R, editor. Intracranial metastases: current management strategies. Malden
                   (MA): Blackwell; 2004. p. 20.
               11.   Posner JB. Brain metastases: 1995. A brief review. J Neurooncol 1996;27:287-93.
               12.  Franchino F, Rudà R, Soffietti R. Mechanisms and therapy for cancer metastasis to the brain. Front Oncol 2018;8:161.
               13.   Cooper JB, Ronecker JS, Tobias ME, Mohan AL, Hillard V, et al. Molecular sequence of events and signaling in brain metastases.
                   Anticancer Res 2018;38:1859-77.
               14.   Svokos KA, Salhia B, Toms SA. Molecular biology of brain metastasis. Int J Mol Sci 2014;15:9519-30.
               15.   Wilhelm I, Molnár J, Fazakas C, Haskó J, Krizbai IA. Role of the blood-brain barrier in the formation of brain metastases. Int J Mol Sci
                   2013;14:1383-411.
               16.   Winkler F. The brain metastatic niche. J Mol Med (Berl) 2015;93:1213-20.
               17.   Hugen N, Van de Velde CJH, De Wilt JHW, Nagtegaal ID. Metastatic pattern in colorectal cancer is strongly influenced by histological
                   subtype. Ann Oncol 2014;25:651-7.
               18.   Beasley KD, Toms SA. The molecular pathobiology of metastasis to the brain: a review. Neurosurg Clin N Am 2011;22:7-14.
               19.   Schellinger PD, Meinck HM, Thron A. Diagnostic accuracy of MRI compared to CC in patients with brain metastases. J Neurooncol
                   1999;44:275-81.
               20.   Kramer RA, Janetos GP, Perlstein G. An approach to contrast enhancement in computed tomography of the brain. Radiology
                   1975;116:641-7.
               21.   Ferrigno D, Buccheri G. Cranial computed tomography as a part of the initial staging procedures for patients with non-small-cell lung
                   cancer. Chest 1994;106:1025-9.
               22.   Sze G, Milano E, Johnson C, Heier L. Detection of brain metastases: comparison of contrast-enhanced MR with unenhanced MR and
                   enhanced CT. Am J Neuroradiol 1990;11:785-91.
               23.   Hakyemez B, Erdogan C, Gokalp G, Dusak A, Parlak M. Solitary metastases and high-grade gliomas: radiological differentiation by
                   morphometric analysis and perfusion-weighted MRI. Clin Radiol 2010;65:15-20.
               24.   Ishimaru H, Morikawa M, Iwanaga S, et al. Differentiation between high-grade glioma and metastatic brain tumor using single-voxel
                   proton MR spectroscopy. Eur Radiol 2001;11:1784-91.
               25.   Chiang IC, Kuo YT, Lu CY, Yeung KW, Lin WC, et al. Distinction between high-grade gliomas and solitary metastases using peritumoral
                   3-T magnetic resonance spectroscopy, diffusion, and perfusion imagings. Neuroradiol 2004;46:619-27.
               26.  Chuang MT, Liu YS, Tsai YS, Chen YC, Wang CK. Differentiating radiation-induced necrosis from recurrent brain tumor using MR
                   perfusion and spectroscopy: a meta-analysis. PLoS One 2016;11:e0141438.
               27.  Wang Q, Zhang J, Xu W, Chen X, Zhang J, et al. Role of magnetic resonance spectroscopy to differentiate high-grade gliomas from
   64   65   66   67   68   69   70   71   72   73   74